Squamous Cell Carcinoma of Skin near Brooksville, FL

Care Philosophy: Dr Saeed is anAssociate Member in the Moffitt Malignant Hematology program. Heearned his MD at the University of Baghdad, College of Medicine, Iraq. He completed a post-doctoral fellowship at the University of Kentucky, College of Pharmacy, in Dr Abeer Al-Ghananeem's Lab. Dr Saeed completed an Internal Medicine Residency and Hematology and Medical Oncology Fellowship, and he served as Chief Fellow at the University of Kentucky. Prior to Moffitt,Dr Saeedpracticed at the University of Kentucky, where he was appointed as an Assistant Professor in the Department of Internal Medicine, Division of Hematology and Blood and Marrow Transplantation, College of Medicine.Dr Saeed specializes in treating blood cancers.

Care Philosophy: Dr Jaglal completed his hematology/oncology fellowship at the University of South Florida and Moffitt Cancer Center. His research interests are in benign hematologic disorders: hemophilia, von Willebrand's disease, anemias, hemostasis and thrombosis disorders. Clinically, Dr Jaglal is a hematologist/oncologist and member of Moffitt Medical Group in the Satellite and Community Oncology Department practicing at Tampa General Hospital and Moffitt international Plaza. The MMG faculty at TGH provides invaluable oncology services to the large patient population of this leading regional hospital.

Biography: Dr. Satish Mahara is a Clinical Assistant Member in the Department of Satellite and Community Oncology. Dr. Maharaj received his MD degree from the University of the West Indies. He completed an Internal Medicine Residency at University of Florida Health, Jacksonville. He then completed a Hematology and Oncology Fellowship at the University of Louisville, Brown Cancer Center, Kentucky. Dr. Maharaj joins us from Texas Tech University, Paul L Foster School of Medicine, where he was an Assistant Professor and attending physician in Hematology and Oncology at the University Medical Center, El Paso. Dr. Maharaj's clinical focus is on the treatment of gastrointestinal and head and neck cancers, including oral cavity, oropharyngeal, esophageal, gastric, colorectal, liver, pancreatic, and anal cancers. His research focuses on investigating the use of various biomarkers to better classify, treat and monitor cancer and the potential adverse effects of therapy.